Category: Press Release - Page 143 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders

Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders

Post published:March 16, 2021
Post category:Press Release

Read more about the article Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Red Light Holland Successfully Completes Sale and Import of iMicrodose Psychedelic Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Post published:March 16, 2021
Post category:Press Release

Read more about the article Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

Post published:March 16, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Provides Update on European Operations

Mydecine Innovations Group Provides Update on European Operations

Post published:March 16, 2021
Post category:Press Release

Read more about the article DC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi

DC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi

Post published:March 15, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50% Decrease in Opioid Self-Administration in a Predictive Rodent Model

Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50% Decrease in Opioid Self-Administration in a Predictive Rodent Model

Post published:March 15, 2021
Post category:Press Release

Read more about the article IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation

IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX Graduation

Post published:March 15, 2021
Post category:Press Release

Read more about the article MINDCURE Names Tarik Lebbadi as Chief Operating Officer

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Post published:March 15, 2021
Post category:Press Release

Read more about the article Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

Post published:March 15, 2021
Post category:Press Release

Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 million

Post published:March 15, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.